Pain Medicine Doctors in Birmingham, AL Accepting Medicare

5 Pain Medicine doctors found. Showing 1 - 5

Dr. Kenneth G Varley, M.D. Pain Medicine - Interventional Pain Medicine Medicare: Accepting Medicare Assignments Practice Location: 7500 Hugh Daniel Dr Ste 360, Birmingham, AL 35242 Phone: 205-995-9967    Fax: 205-995-0635

Dr. Michael Scott Kendrick, MD Pain Medicine - Interventional Pain Medicine Medicare: Accepting Medicare Assignments Practice Location: 1020 26th St S, Suite 100, Birmingham, AL 35205 Phone: 205-332-3155    Fax: 205-332-3162

Dr. James Gillespie, M.B.B.S. Pain Medicine - Interventional Pain Medicine Medicare: Medicare Enrolled Practice Location: 1020 26th St S # 100, Birmingham, AL 35205 Phone: 205-332-3155

Dr. Sandra Lynne Durham, M.D. Pain Medicine - Pain Medicine Medicare: Not Enrolled in Medicare Practice Location: 6801 Cahaba Valley Rd, Ste 208, Birmingham, AL 35242 Phone: 205-222-7651

Brandon Schyler Brooks, MD Pain Medicine - Interventional Pain Medicine Medicare: Accepting Medicare Assignments Practice Location: 619 19th St S, Birmingham, AL 35249 Phone: 205-934-4011    Fax: 205-930-8985

News Archive

Emtec to demonstrate thin client solution at HIMSS 2010 Conference and Exhibition

Emtec, Inc., a systems integrator, announced today that it will demonstrate its thin client solution for healthcare in the Avnet booth #7467 at the HIMSS 2010 Conference and Exhibition. This solution integrates the ThinIdentity™ virtual desktop infrastructure solution, smart card technology and stateless thin-client computing based on the Sun Microsystems™ Sun Ray virtual display client.

Cause of uveal melanoma discovered, most common eye cancer

A University of British Columbia geneticist has discovered a gene mutation that can cause the most common eye cancer - uveal melanoma.

Researchers take important step towards development of future drugs for brain diseases

A successful joint collaboration between researchers at the Hebrew university of Jerusalem and the startup company TyrNovo may lead to a potential treatment of brain diseases. The researchers found that TyrNovo's novel and unique compound, named NT219, selectively inhibits the process of aging in order to protect the brain from neurodegenerative diseases, without affecting lifespan. This is a first and important step towards the development of future drugs for the treatment of various neurodegenerative maladies.

MD Anderson, CATCH Global Foundation partner to lower cancer risk in children

Cancer prevention experts at The University of Texas MD Anderson Cancer Center have allied with the CATCH Global Foundation, whose comprehensive child health program reaches children and their families in more than 10,000 educational settings nationwide, to promote behavior that will lower children's lifelong risk of developing cancer.

Acidic niche within lymph nodes plays integral role in regulating T cell activation

In the fight against cancer, the immune system is the first line of defense. The lymphatic system specifically is essential to protecting the body against foreign invaders.

Read more Medical News

› Verified 6 days ago